Loading...
13 ibuprofen COVID-19 controlled studies, 1 RCTs
https://c19early.org/ibmeta.html
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+ Rinott -21% 1.21 [0.33-4.38] death 3/87 9/316 Improvement, RR [CI] Treatment Control Rinott -12% 1.12 [0.37-3.34] ventilation 4/87 13/316 Rinott -40% 1.40 [0.51-3.81] ICU 5/87 13/316 Abu Esba -170% 2.70 [0.33-22.0] death 1/40 11/357 Abu Esba 37% 0.63 [0.07-5.44] death 40 (n) 357 (n) Abu Esba -45% 1.45 [0.44-4.81] oxygen 40 (n) 357 (n) Abu Esba -18% 1.18 [0.59-2.36] hosp. 40 (n) 357 (n) Abu Esba -85% 1.85 [0.42-8.13] severe case 40 (n) 357 (n) Sobhy (DB RCT) 52% 0.48 [0.24-0.95] ICU 10/90 21/90 OT1 Sobhy (DB RCT) 52% 0.48 [0.24-0.95] oxygen 10/90 21/90 OT1 Sobhy (DB RCT) 26% 0.74 [0.58-0.94] hosp. time 90 (n) 90 (n) OT1 Sobhy (DB RCT) 25% 0.75 [0.17-3.26] no recov. 3/90 4/90 OT1 Sobhy (DB RCT) 43% 0.57 [0.25-1.29] no recov. 8/90 14/90 OT1 Sobhy (DB RCT) 48% 0.52 [0.28-0.95] no recov. 13/90 25/90 OT1 Sobhy (DB RCT) 41% 0.59 [0.37-0.94] no recov. 20/90 34/90 OT1 Choi (PSM) -240% 3.40 [0.64-18.1] progression case control Samimagham -100% 2.00 [1.33-3.02] death 63 (n) 95 (n) Samimagham -428% 5.28 [1.82-15.3] severe case 14/63 4/95 Samimagham -13% 1.13 [1.02-1.25] progression 60/63 80/95 Kragholm 4% 0.96 [0.72-1.23] progression 264 (n) 3,738 (n) Wong -23% 1.23 [0.90-1.68] death population-based cohort Wong 17% 0.83 [0.56-1.25] death population-based cohort Reese (PSM) 9% 0.91 [0.62-1.35] death 5,737 (n) 5,737 (n) Reese (PSM) -303% 4.03 [3.69-4.40] severe case 5,737 (n) 5,737 (n) Drake 10% 0.90 [0.71-1.13] death n/a n/a Leal 3% 0.97 [0.94-1.00] cases n/a n/a Campbell (PSW) 0% 1.00 [0.99-1.01] death 1,814 (n) 20,311 (n) Campbell (PSW) 1% 0.99 [0.98-1.00] death 1,814 (n) 20,311 (n) Xie -12% 1.12 [0.92-1.38] hosp. population-based cohort OT1 Xie -8% 1.08 [0.95-1.22] cases population-based cohort OT1 Loucera 48% 0.52 [0.34-0.78] death 519 (n) 15,449 (n) Ibuprofen COVID-19 outcomes c19 earlyOctober 2023 1 OT: comparison with other treatment Favors ibuprofen Favors control
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit
